Print

Achillion Pharmaceuticals, Inc. (ACHN) Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team  
5/15/2013 9:24:03 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW HAVEN, Conn., May 15, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the appointment of David Apelian, M.D., Ph.D., MBA, to the position of Executive Vice President and Chief Medical Officer, effective May 28, 2013. Dr. Apelian wll assume responsibility for the clinical development of Achillion's portfolio of compounds to treat HCV.

Help employers find you! Check out all the jobs and post your resume.

//-->